Evidence map›Paper›PMID 39440965›Full record

ArticlemSphere2024

Diversity of

Rebecca L Bacon, Carolyn L Hodo, Jing Wu, Shannara Welch, Colette Nickodem, Javier Vinasco, Deborah Threadgill, Stanton B Gray, Keri N Norman, Sara D Lawhon

Abstract read
In one paragraph

Article in mSphere, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Incidence and Pathogenicity ofMicroorganisms · 2026
    Article
  2. A review of chronic enterocolitis of rhesus macaques (Frontiers in veterinary science · 2026
    Review
  3. Review
  4. Article
  5. The Pharmacokinetics of Tulathromycin Following Subcutaneous Administration in Rhesus Macaques (Macaca mulatta).Journal of the American Association for Laboratory Animal Science : JAALAS · 2025
    Article
  6. Diversity ofmSphere · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rebecca L BaconDepartment of Veterinary Pathobiology, School of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, Texas, USA.ORCID 0000-0002-4941-682X
Carolyn L HodoMichale E. Keeling Center for Comparative Medicine and Research, The University of Texas MD Anderson Cancer Center, Bastrop, Texas, USA.ORCID 0000-0003-4113-7081
Jing WuDepartment of Veterinary Pathobiology, School of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, Texas, USA.
Shannara WelchVeterinary Medical Teaching Hospital, School of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, Texas, USA.
Colette NickodemDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID 0000-0002-3064-5833
Javier VinascoDepartment of Veterinary Pathobiology, School of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, Texas, USA.
Deborah ThreadgillDepartment of Cell Biology and Genetics, School of Medicine, Texas A&M University, College Station, Texas, USA.
Stanton B GrayMichale E. Keeling Center for Comparative Medicine and Research, The University of Texas MD Anderson Cancer Center, Bastrop, Texas, USA.
Keri N NormanDepartment of Veterinary Integrative Biosciences, School of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, Texas, USA.ORCID 0000-0002-1152-0664
Sara D LawhonDepartment of Veterinary Pathobiology, School of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, Texas, USA.ORCID 0000-0001-9154-8909

Funding

Comparative Biomedical Research Training for VeterinariansT32OD011083 · OD · TEXAS A&M AGRILIFE RESEARCH · PI ALBERT MULENGA · 2012 to 2026
$4.8M
FDA Vet-LIRN Site Application –AgriLife and the Texas A&M University SystemU18FD006171 · FDA · TEXAS A&M AGRILIFE RESEARCH · PI Sara D. Lawhon · 2017 to 2026
$474k
Validation of methods for detection of Campylobacter in veterinary patientsU18FD005013 · FDA · TEXAS A&M AGRILIFE RESEARCH · PI LAWHON, SARA D., SUCHODOLSKI, JAN · 2013 to 2015
$278k
Expansion of the capacity of the TAMU VMTH Clinical Microbiology LaboratoryU18FD006664 · FDA · TEXAS A&M AGRILIFE RESEARCH · PI LAWHON, SARA D. · 2019 to 2019
$63k
Validation of Gyr Primers for Detection of Campylobacter Jejuni in Canine FecesU18FD006446 · FDA · TEXAS A&M AGRILIFE RESEARCH · PI LAWHON, SARA D. · 2018 to 2018
$14k
FDA HHS U18 FD005013FDA HHS U18 FD006171FDA HHS U18 FD006446FDA HHS U18 FD006664NIH HHS T32 OD011083ODCDC CDC HHS T32 OD011083
6 · The paper itself

Abstract

IMPORTANCE: Gastrointestinal disease is one of the most common reasons for hospitalization in non-human primate colonies and accounts for over one-third of non-research related euthanasia. In rhesus macaques, this manifests as both acute diarrhea and chronic enterocolitis (CE), a syndrome of chronic diarrhea resulting in poor weight gain or weight loss which is minimally responsive to treatment.

Indexed as

Anti-Bacterial AgentsCampylobacter InfectionsCampylobacter jejuniMacaca mulattaWhole Genome SequencingAnimalsCampylobacterCampylobacter coliDiarrheaDrug Resistance, Multiple, BacterialFecesFemaleGenetic VariationGenotypeMaleMonkey DiseasesAnti-Bacterial AgentsCampylobacterCampylobacter coliCampylobacter jejunichronic enterocolitisdiarrheamacaquepost-infectious irritable bowelrhesus macaque

Identifiers

PMID39440965
PMCPMC11580467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.